LD-2 disclosure · 4th Quarter - Report (No Activity)NEPHCUREvia NEPHCURE4th Quarter (Oct 1 - Dec 31) · 2025Posted Feb 5, 2026Filing document ↗LDA record ↗Coverage · No income or expenses were reported on this filing.ClientNameNEPHCUREDescriptionRare kidney disease patient advocacy organizationLocationPennsylvania · United States of AmericaRegistrantFirmNEPHCURELocationPhiladelphia, Pennsylvania, United States of America